Form 8-K/A - Current report: [Amend]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 14, 2025 (December 2, 2024)

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)



Delaware	001-34504	20-5340172
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

    6303 Cowboys Way, Suite 600
Frisco, Texas

    75034

    (Address of principal executive offices)

    (Zip Code)

(469) 535-8200

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))


☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	ADUS	The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company. ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

On December 2, 2024, Addus HomeCare Corporation (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) with the Securities and Exchange Commission to report that, on December 2, 2024, Addus HealthCare, Inc., an Illinois corporation (“Addus HealthCare”), a wholly-owned subsidiary of the Company, completed its acquisition of the personal care business (the “Acquired Business”) of Curo Health Services, LLC, a Delaware limited liability company, which does business as Gentiva (“Gentiva”). The financial statements of KAH Hospice Company-Personal Care are in Exhibit 99.1 and we refer to KAH Hospice Company-Personal Care as Gentiva. This Current Report on Form 8-K/A amends the Original Form 8-K to include Item 9.01 set forth below and provide the audited financial statements of the Acquired Business as of, and for the year ended December 31, 2023, the unaudited financial statements of the Acquired Business as of, and for the nine month period ended, September 30, 2024 and the unaudited pro forma combined financial statements as of, and for the nine month period ended, September 30, 2024, and for the year ended December 31, 2023. All other disclosures contained in the Original Form 8-K remain unchanged.


Item 9.01	Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired.

The historical audited combined financial statements of KAH Hospice Company-Personal Care as of, and for the year ended, December 31, 2023, are filed herewith as Exhibit 99.1 to this report and incorporated herein by reference.

The historical unaudited condensed combined financial statements of KAH Hospice Company-Personal Care for the nine months ended September 30, 2024, are filed herewith as Exhibit 99.2 to this report and incorporated herein by reference.

(b) Pro Forma Financial Information.

The unaudited pro forma combined financial statements as of December 31, 2023, and for the nine month period ended, September 30, 2024, are filed herewith as Exhibit 99.3 to this report and incorporated herein by reference.

(d) Exhibits:



Exhibit No.		Description

23.1		Consent of PricewaterhouseCoopers, an independent registered public accounting firm, with respect to the audited financials of Gentiva

99.1		Audited combined financial statements of KAH Hospice Company-Personal Care as of, and for the year ended, December 31, 2023, the related notes and the related independent auditors’ report

99.2		Unaudited condensed combined financial statements of KAH Hospice Company-Personal Care for the nine months ended September 30, 2024

99.3		Unaudited pro forma combined financial information and the related notes

104		Cover Page Interactive Data File (embedded within Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



	ADDUS HOMECARE CORPORATION

Date: February 14, 2025	By	/s/ Brian Poff
		Brian Poff
		Chief Financial Officer

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-267253) and on Form S-8 (Nos. 333-272871, 333-219946, 333-190433, and 333-164413) of Addus HomeCare Corporation of our report dated February 12, 2025 relating to the financial statements of KAH Hospice Company-Personal Care (a carve-out business of KAH Hospice Co, Inc.), which appears in this Current Report on Form 8-K.

/s/ PricewaterhouseCoopers LLP
Nashville, TN
February 14, 2025

Exhibit 99.1

KAH Hospice Company-Personal Care

(A carve-out business of KAH Hospice Company, Inc.)

Combined Financial Statements for the Year Ended December 31, 2023

KAH Hospice company-PERSONAL CARE

Index

Page

Report of Independent Auditors

To the Management of KAH Hospice Company Inc.:

Opinion

We have audited the accompanying combined financial statements of KAH Hospice Company-Personal Care (a carve- out business of KAH Hospice Company, Inc.) (the "Company"), which comprise the combined balance sheet as of December 31, 2023, and the related combined statement of operations, of net parent investment and of cash flows for the year then ended, including the related notes (collectively referred to as the "combined financial statements").

In our opinion, the accompanying combined financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for the year then ended in accordance with accounting principles generally accepted in the United States of America.

Basis for Opinion

We conducted our audit in accordance with auditing standards generally accepted in the United States of America (US GAAS). Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Audit of the Combined Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Responsibilities of Management for the Combined Financial Statements

Management is responsible for the preparation and fair presentation of the combined financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of combined financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the combined financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the combined financial statements are available to be issued.

Auditors' Responsibilities for the Audit of the Combined Financial Statements

Our objectives are to obtain reasonable assurance about whether the combined financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with US GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the combined financial statements.

In performing an audit in accordance with US GAAS, we:

•

Exercise professional judgment and maintain professional skepticism throughout the audit.

•

Identify and assess the risks of material misstatement of the combined financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the combined financial statements.

•

Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.

•

Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the combined financial statements.

•

Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/PricewaterhouseCoopers LLP

Nashville, Tennessee

February 14, 2025

kAh hospice company-Personal CARE

COMBINED STATEMENT OF OPERATIONS

(In thousands)

See Accompanying Notes to Combined Financial Statements.

kAh hospice company-Personal CARE

COMBINED BALANCE SHEET

(In thousands)

See Accompanying Notes to Combined Financial Statements.

kAh hospice company-Personal CARE

COMBINED STATEMENT OF NET PARENT INVESTMENT

(In thousands)

See Accompanying Notes to Combined Financial Statements.

kAh hospice company-Personal CARE

COMBINED STATEMENT OF CASH FLOWS

(In thousands)

See Accompanying Notes to Combined Financial Statements.

kah hospice company-Personal care

Notes to COMBINED financial statements

Note 1. Basis of Presentation

Reporting Entity

KAH Hospice Company-Personal Care (“the Company”) is an operating division of KAH Hospice Company, Inc. (“KAH”) The division provides personal care services for patients in a variety of settings, including their homes, nursing centers, and other residential settings. The Company provides services in 49 locations in 7 states as of December 31, 2023.

On August 11, 2022, Clayton, Dubilier & Rice (“CD&R”) purchased 60% of the Equity interests of KAH from Humana, Inc. Previously, Humana owned 100% of the equity interests of KAH.

On June 8, 2024, Curo Health Services, LLC (“Curo”), a subsidiary of KAH, entered into a Stock and Asset Purchase agreement with Addus Healthcare, Inc. Under the terms of the agreement, Curo sold the Company as defined as all of the outstanding equity interests in wholly owned subsidiaries of IntegraCare of Abilene, LLC, NP Plus, LLC, Girling Health Care Services of Knoxville, Inc. and Girling Health Care, Inc. as well as, certain assets relating to the personal care business from its wholly owned subsidiaries Central Arizona Home Health Care, Inc., Community Home Care & Hospice, LLC, TNMO Healthcare, LLC and Odyssey HealthCare Operating A, LP. Together, the outstanding equity interests and assets of the Company were purchased for $350 million. The transaction was finalized on December 2, 2024.

Principles of combination

The accompanying combined financial statements of the Company and its subsidiaries have been derived from the combined financial statements and accounting records of KAH as if the Company had operated on a stand-alone basis during the periods presented and were prepared utilizing the management approach, in accordance with generally accepted accounting principles in the United States of America (“GAAP”).

The income tax amounts in these combined financial statements have been calculated based on a separate return

methodology and are presented as if the Company’s income gave rise to separate federal and state consolidated income tax return filing obligations in the respective jurisdictions in which it operates. In addition to various separate state and local income tax filings, the Company joins with KAH in various U.S. federal, state and local consolidated income tax filings.

The combined financial statements include an allocation of expenses related to certain KAH corporate functions as discussed in Note 9. The combined financial statements also include revenues and expenses directly attributable to the Company and assets and liabilities specifically attributable to the Company. KAH’s third-party debt and related interest expense have not been attributed to the Company, because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. The entities combined in these financial statements were part of KAH’s Collateral and Guarantee Requirement agreement pursuant to which the Company agreed, jointly and severally, fully and unconditionally to guarantee all of KAH’s obligations under the credit agreement. Additionally, the Company is part of KAH’s security agreement, pursuant to which a first-priority security interest was granted in substantially all present and future real, personal and intangible assets, including the pledge of 100 percent of all outstanding capital stock of the Company’s subsidiaries to secure full payment of the obligations for the ratable benefit of the lenders. Net parent investment represents the Company’s cumulative earnings as adjusted for cash distributions and cash contributions from its parent.

The Company eliminates all intercompany transactions within the Company from its financial results. Transactions between the Company and KAH have been included in these combined financial statements. The transfers with KAH that are not expected to be settled are reflected in net parent investment on the combined balance sheet and combined statement of net parent investment. Within the combined statement of cash flow, these transfers are treated as an operating, financing or noncash activity determined by the nature of the transactions. Transactions between the Company and KAH or between the Company and Humana are considered related party transactions. Refer to Note 9 for more information regarding related party transactions.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

Recently issued accounting requirements

In June 2016, the FASB issued ASU 2016-13, ‘‘Financial Instruments-Credit Losses’’ (“ASU 2016- 13”). ASU 2016-13 requires entities to report ‘‘expected’’ credit losses on financial instruments and other commitments to extend credit rather than the current ‘‘incurred loss’’ model. These expected credit losses for financial assets held at the reporting date are to be based on historical experience, current conditions, and reasonable and supportable forecasts. This ASU requires enhanced disclosures relating to significant estimates and judgments used in estimating credit losses, as well as the credit quality. ASU 2016-13 is effective for the Company for annual reporting periods beginning after December 15, 2022. The Company adopted ASU 2016-13 effective January 1, 2023 using the modified retrospective approach and revised its accounting policies and processes to facilitate this approach. The adoption of ASU 2016-13 did not have an impact on the Company’s financial statements.

In December 2023, the FASB issued ASU 2023-09, Improvement to Income Tax Disclosures, which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, may be applied prospectively or retrospectively, and allows for early adoption. These requirements are not expected to have an impact on the Company’s financial statements and will expand income tax disclosures.

In November 2024, the FASB issued ASU No. 2024-03 ("ASU 2024-03"), Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which is intended to improve disclosures about a public business entity's expenses, primarily through additional disaggregation of income statement expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted. The amendments in ASU 2024-03 should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the ASU to determine the impact on the Company's disclosures.

Summary of significant accounting policies

Use of estimates

The preparation of the financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions are used for, but not limited to: (1) revenue reserves for contractual adjustments and uncollectible amounts; (2) fair value of acquired assets and assumed liabilities in business combinations; (3) asset impairments, including goodwill; and (4) corporate allocations. Future events and their effects cannot be predicted with certainty; accordingly, the Company’s accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could differ from those estimates.

Revenues

Net revenue from contracts with customers is recognized in the period in which the performance obligations are satisfied under the Company’s contracts by transferring the requested services to patients in amounts that reflect the consideration which is expected to be received in exchange for providing patient care, which is the transaction price allocated to the services provided in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, and all of the related amendments. Net revenue is recognized as performance obligations are satisfied, which can vary depending on the type of services provided. The performance obligation is the delivery of patient care in accordance with the requested services outlined in physicians’ orders or state program referrals, which are based on the specific needs of each patient.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

The performance obligations are associated with contracts in duration of less than one year; therefore, the optional exemption provided by ASC 606 was elected resulting in the Company not being required to disclose the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied or partially unsatisfied as of the end of the reporting period.

The Company determines the transaction price based on gross charges for services provided, reduced by estimates for explicit and implicit price concessions. The Company’s estimates of contractual adjustments and uncollectible amounts require the exercise of judgment. Explicit price concessions include contractual adjustments provided to various payers. They are recorded for the difference between the Company’s standard rates and the contracted rates to be realized from patients and third-party payers. Implicit price concessions include discounts provided to self-pay, uninsured patients or other payers, adjustments resulting from regulatory reviews, audits, billing reviews and other matters and are estimated by the Company based on historical collection experience and success rates in the claim appeals and adjudication process. The Company assesses the ability to collect for the services provided at the time of patient admission based on the verification of the patient’s insurance coverage under Medicaid, commercial insurance and other payers. Subsequent changes to the estimate of the transaction price are recorded as adjustments to net revenue in the period of change. Subsequent changes that are determined to be the result of an adverse change in the patient’s ability to pay (i.e. change in credit risk) based on a review of account aging and direct contract with payors are recorded as a provision for doubtful accounts within selling, general and administrative expenses.

A summary of revenue by payer type follows (in thousands):

Sources of net revenue fall into Medicaid, commercial insurance, and other payers. Reimbursement is based on each payer’s predetermined fee schedule applied to each service provided. Revenue is therefore recognized as services are provided based on these various fee schedules.

Deferred Revenue

The American Rescue Plan Act of 2021 (“ARPA”) is a relief package with numerous provisions that affect healthcare providers and was signed into law in March 2021. ARPA provides for relief funding for eligible state, local, territorial, and Tribal governments to mitigate the fiscal effects of the COVID-19 public health emergency. Additionally, the law provides for a 10-percentage point increase in federal matching funds for Medicaid home and community-based services (“HCBS”) from April 1, 2021, through March 31, 2022, provided the state satisfied certain conditions. States are permitted to use the state funds equivalent to the additional federal funds through March 31, 2025. States must use the monies attributable to this matching fund increase to supplement, not supplant, their level of state spending for the implementation of activities enhanced under the Medicaid HCBS in effect as of April 1, 2021.

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g. efforts to recruit and retain direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses. In total, the Company received state funding provided by ARPA in aggregate amount of $25.1 million, of which, $0.5 million was received during the year ended December 31, 2023. During the year ended December 31, 2023, the Company recorded revenue of $14.9 million and related costs of services sold of approximately $13.7 million. As of December 31, 2023, the deferred portion of ARPA funding was $7.6 million and is reflected on the combined balance sheet.

Cash

Cash includes amounts on deposit with several major financial institutions in excess of the maximum amount insured by the Federal Deposit Insurance Corporation. The Company participates in a centralized cash management arrangement whereby excess cash balances are swept into a master account that is legally owned by KAH. The amount

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

of cash on the combined balance sheet represents the balances not swept to the master account owned by KAH as of December 31, 2023.

Accounts receivable

Accounts receivable consist primarily of amounts due from the Medicaid program, other government programs, managed care health plans, commercial insurance companies and individual patients. Accounts receivable from services rendered are reported at their estimated transaction price which takes into account price concessions from the various payers. The concentration of accounts receivable by payer class as a percentage of total net accounts receivable is as follows:

While revenues and accounts receivable from the Medicaid program are significant to its operations, the Company does not believe there are significant credit risks associated with this government agency. The Company does not believe there are any other significant concentrations of revenues from any particular payer that would subject us to any significant credit risks in the collection of accounts receivable.

Accounts requiring collection efforts are reviewed by patient account representatives, who employ various collection efforts, including contacting the applicable parties, providing financial or clinical information to allow for payment or to overturn payer decisions to deny payment, and arranging payment plans, among other techniques. When in-house efforts are exhausted or it is a more prudent use of resources, commercial insurance and other accounts may be turned over to a collection agency.

The collection of outstanding receivables from Medicaid is the Company’s primary source of cash and is critical to its operating performance. While it is the Company’s policy to verify eligibility for these programs prior to a patient being admitted, there are some circumstances in which that verification by the payer may take some period of time.

If actual results are not consistent with the Company’s assumptions and judgments, the Company may be exposed to gains or losses that could be material. Changes in general economic conditions, federal or state governmental programs, payer mix or business office operations could affect the Company’s collection of accounts receivable, financial position, results of operation and cash flows.

Property and equipment

Property and equipment is carried at cost less accumulated depreciation. Depreciation expense, computed by the straight-line method, was $0.8 million for the year ended December 31, 2023. The depreciable lives for the Company’s property and equipment, other than leasehold improvements, generally range from 1 to 7 years. See Note 2 for additional information about useful lives. Leasehold improvements are depreciated over their estimated useful lives or the remaining lease term, whichever is shorter. Repairs and maintenance are expensed as incurred.

Long-lived assets

The Company reviews the carrying value of certain long-lived assets and finite-lived intangible assets with respect to any events or circumstances that indicate an impairment or an adjustment to the amortization period is necessary. If circumstances suggest that the recorded amounts cannot be recovered based upon estimated future undiscounted cash flows, the carrying values of such assets are reduced to fair value.

In assessing the carrying values of long-lived assets, the Company estimates future cash flows at the lowest level for which there are independent, identifiable cash flows. Generally, sites of service at a geographical location level within the Company are considered the lowest level for which there are independent, identifiable cash flows.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

Goodwill and Indefinite-lived Intangible Assets

The Company is required to test goodwill and other indefinite-lived intangible assets for impairment on an annual basis and between annual tests if current events or circumstances require an interim impairment assessment. The Company has recognized goodwill upon the acquisition of the assets or stock of another third-party business operation. The Company has determined that its personal care program constitutes a reporting unit. Accounting guidance allows the Company to perform a qualitative assessment about the likelihood of the carrying value of a reporting unit or an indefinite-lived intangible asset exceeding its fair value, referred to as the step zero assessment. The step zero assessment requires the evaluation of certain qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors and overall financial performance, as well an assessment indicates that it is more likely than not that the fair value of a reporting unit or indefinite-lived intangible asset is less than the carrying value amount, then the Company would perform a quantitative impairment test. If, after assessing these events and circumstances, it is determined that there may be an impairment, then a quantitative analysis is performed. With the quantitative analysis, the Company compares the fair value of its reporting units to the carrying amount of the units’ net assets to determine if there is a potential impairment of goodwill. If the estimated fair value of the reporting unit exceeds the carrying value, the goodwill is not impaired, and no further review is required. The Company would recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. To determine the fair value of the reporting units, the Company uses the combination of a present value (discounted cash flow) technique and a market-based approach or other valuation methodologies and reasonableness tests, as appropriate.

Determining the fair value of a reporting unit is judgmental in nature and requires the use of significant estimates and assumptions, including long-term growth rates, operating margins, and discount rates, as well as relevant comparable company revenue and earnings multiples for the market-based approach. The future occurrence of a potential indicator of impairment, such as, but not limited to, a significant adverse change in legal factors or business climate, reductions of projected patient census, an adverse action or assessment by a regulator, as well as other unforeseen factors, would require an interim assessment for some or all of the reporting units and could have a material impact on the Company’s combined financial statements. See Note 3 for information on the Company’s impairment testing.

The Company is required to annually compare the fair values of other indefinite-lived intangible assets, which includes certificates of need (“CONs”), to their carrying amounts. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized. Fair values of other indefinite-lived intangible assets are determined based on an income approach.

The Company performed its annual impairment assessment for goodwill of its personal care reporting unit as well as its indefinite-lived CONs at October 1, 2023. The Company performed a quantitative analysis using a combination of the income approach, utilizing a discounted cash flow analysis, and the market approach, utilizing the guideline public company method. Based on the results of the annual quantitative assessment conducted as of October 1, 2023, the fair value of the Company’s reporting unit exceeded their carrying values, and management concluded that no impairment charge was warranted. Based on the impairment assessment performed over the Company’s indefinite-lived CONs, the fair value exceeded the carrying value of the assets, and management concluded that no impairment charge was warranted.

Leases

The Company evaluates whether a contract is or contains a lease at the inception of the contract. Upon lease commencement, the date on which a lessor makes the underlying asset available to the Company for use, the Company classifies the lease as either an operating or finance lease. The Company’s facility leases are classified as operating leases.

The Company recognizes a right-of-use (“ROU”) asset and lease liability at lease commencement. A ROU asset represents the Company’s right to use an underlying asset for the lease term, while the lease liability represents an obligation to make lease payments arising from a lease which are measured on a discounted basis. The Company elected the short-term exemption for leases with an initial term of 12 months or less and therefore those leases are not recorded on the combined balance sheet.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

Lease liabilities are measured at the present value of the remaining fixed lease payments at commencement. The Company’s leases may also specify extension or termination clauses, which are factored into the measurement of the lease liability when it is reasonably certain that the Company will exercise these options. The Company has also elected to account for its lease and non-lease components, such as common area maintenance, as a single lease component for its leases, when the non-lease component is fixed or included in the base rent. When the Company makes payments which are not fixed at lease commencement, they will be expensed as incurred.

Allocated expense

Amounts were allocated from KAH for costs attributable to the operations of the Company. The expenses incurred by KAH include costs from certain support center and shared service functions provided by KAH to the Company.

All support center costs that were specifically identifiable to the Company have been allocated to the Company and are included in the accompanying combined statement of operations. The results of operations for the Company include allocations for certain support functions that were previously provided on a centralized basis by KAH to all or part of the Company, including cash management, information technology services, accounts receivable oversight, property and equipment record keeping, accounts payable processing, payroll and general bookkeeping. Additionally, KAH manages general business functions on behalf of the Company, including human resources, financial reporting and legal services. KAH refers to these expenses as support center allocations and, where specific identification of charges attributable to the Company was not practicable, such costs have been allocated based on a percentage of net revenues.

In the opinion of management, the cost allocations have been determined on a reasonable basis and include all the costs of doing business. The amounts that would have been or will be incurred on a stand-alone basis could differ from the amounts allocated due to economies of scale, management judgment, or other factors. See Note 9 for additional information regarding related party transactions.

Income Taxes

The Company has adopted the separate return approach for the purpose of the combined financial statements, including the income tax provisions and the related deferred tax assets and liabilities. The historic operations of the Company business reflect a separate return approach for each jurisdiction in which the Company had a presence and KAH filed a tax return.

The Company provides for income taxes using the asset and liability method. This approach recognizes the amount of income taxes payable or refundable for the current year, as well as deferred tax assets and liabilities for the future tax consequence of events recognized in the combined financial statements and income tax returns. Deferred income tax assets and liabilities are adjusted to recognize the effects of changes in tax laws or enacted tax rates.

A valuation allowance is required when it is more likely than not some portion of the deferred tax assets will not be realized. Realization is dependent on generating sufficient future taxable income in the applicable tax jurisdiction. On a quarterly basis, the Company assesses the likelihood of realization of the deferred tax assets considering all available evidence, both positive and negative. The Company’s most recent operating performance, the scheduled reversal of temporary differences, the forecast of taxable income in future periods by jurisdiction, the ability to sustain a core level of earnings, and the availability of prudent tax planning strategies are important considerations in this assessment.

The Company evaluates its tax positions and establishes assets and liabilities in accordance with the applicable accounting guidance on uncertainty in income taxes. The Company reviews these tax uncertainties in light of changing facts and circumstances, such as the progress of tax audits, and adjusts them accordingly.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

Note 2. Fixed Assets, Net

Fixed assets, net at December 31, 2023 were as follows (in thousands):

Depreciation expense was $0.8 million in the year ended December 31, 2023.

Note 3. Goodwill and Identifiable Intangible Assets

Goodwill and indefinite-lived intangible assets primarily originated from business combinations accounted for as purchase transactions. Under business combination accounting, assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The Company’s indefinite-lived intangible assets consist of CONs.

Goodwill

The amount of goodwill at December 31, 2023 was approximately $287.7 million. There were no changes to goodwill during the year ended December 31, 2023.

In accordance with the authoritative guidance for goodwill and other intangible assets, the Company is required to perform an impairment test for goodwill and indefinite-lived intangible assets at least annually or more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. The Company performs its annual goodwill impairment test on October 1 each fiscal year.

A reporting unit is either an operating segment or one level below the operating segment, referred to as a component. The Company has determined that its personal care program constitutes a reporting unit. The measurement of goodwill impairment is the amount by which the carrying amount exceeds the reporting unit’s fair value, not to exceed the carrying amount of goodwill.

Based upon the results of the annual impairment test for goodwill at October 1, 2023, no impairment charges were recorded.

Since quoted market prices for the Company’s reporting unit are not available, the Company applies judgment in determining the fair value of the reporting unit for purposes of performing the goodwill impairment test. The Company relies on widely accepted valuation techniques, including a discounted cash flow approach and a market-based approach, which capture both the future income potential of the reporting unit and the market behaviours and actions of market participants in the industry that includes the reporting unit. These types of analyses require the Company to make assumptions and estimates regarding future cash flows, industry-specific economic factors and the profitability of future business strategies. The discounted cash flow approach uses a projection of estimated operating results and cash flows that are discounted using a discount rate that corresponds to a market-based weighted-average cost of capital. Under the discounted cash flow approach, the projection uses management’s best estimates of economic and market conditions over the projected period for each reporting unit including long-term growth rates for future revenue and operating margins. Other significant estimates and assumptions include terminal value growth rates and discount rates. The market-based approach estimates fair value by applying revenue and earnings multiples to the reporting unit’s operating results. The multiples are derived from comparable publicly traded companies with similar operating and investment characteristics to the reporting units.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

Adverse changes in the operating environment and changes in key assumptions used to determine the fair value of the Company’s reporting unit and indefinite-lived intangible assets may result in future impairment charges for a portion or all of these assets. Specifically, if the rate of growth of government and commercial revenues earned by the Company were to be less than projected, if healthcare reforms were to negatively impact the Company’s business, or if recent increases in labor costs materially exceed the Company’s projections in its reporting units, an impairment charge of a portion or all of these assets may be required. An impairment charge could have a material adverse effect on the Company’s financial position and results of operations, but it would not be expected to have an impact on the Company’s business or liquidity.

Identifiable Intangible Assets

The Company’s indefinite-lived intangible assets consist of CONs. The fair values of the Company’s indefinite-lived intangible assets are derived from current market data, including comparable sales or royalty rates, and projections at a geographical location level or reporting unit, which include management’s best estimates of economic and market conditions over the projected period. Significant assumptions include growth rates in the number of admissions, patient days, reimbursement rates, operating costs, terminal value growth rates, changes in working capital requirements, weighted-average cost of capital and opportunity costs.

The Company performs its annual indefinite-lived intangible asset impairment tests on October 1 each fiscal year. Based upon the results of the impairment test for indefinite-lived intangible assets discussed above, no impairment charges were recorded. The fair value of the CONs was measured using an income approach based on the consideration of Level 3 inputs, such as last twelve months’ revenue and EBITDA.

A summary of identifiable intangible assets at December 31, 2023 follows (in thousands):

Amortization expense was $1.2 million in the year ended December 31, 2023.

Amortization expense for future periods is as follows:

Note 4. Leases

Operating Leases

The Company leases real estate under operating lease arrangements. Real estate is leased primarily for office space. The leases generally have initial terms of three to five years, and many include multi-year renewal options. The Company’s lease arrangements may contain both lease and non-lease components. The Company has elected to combine and account for lease and non-lease components as a single lease component for its real estate leases.

Payments under the Company’s operating lease arrangements are fixed as per the lease arrangements. Lease costs associated with the Company’s operating leases were as follows:

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

The following table shows right-of-use assets and lease liabilities under operating leases at December 31, 2023 (in thousands):

Supplemental cash flow information related to operating leases was as follows (in thousands):

Operating lease liability maturities at December 31, 2023 are as follows (in thousands):

The weighted-average remaining lease term and discount rate related to the Company’s operating lease liabilities as of December 31, 2023 were 3.6 years and 8.26%. As the Company’s leases do not provide an implicit interest rate, the Company used KAH’s incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

At December 31, 2023, the Company has $0.3 million of future payments under leases that had not yet commenced. These leases will commence in 2024 with lease terms ranging from 3 to 5 years.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

Note 5. Income Taxes

The significant components of the provision for income tax expense are as follows (in thousands):

A reconciliation of differences between the federal income tax at statutory rates and the actual income tax expense from operations, which includes federal, state and other income taxes, is presented below:

Federal and state tax credits consist of credits earned from the Work Opportunity Tax Credit (WOTC) program that is earned from hiring and employing individuals from certain targeted groups who face barriers to employment.

Deferred income taxes are determined based on the difference between financial statement and tax basis of assets and liabilities using enacted tax laws and rates. Deferred income taxes as of December 31, 2023, reflect the effect of temporary differences between the amounts of assets and liabilities for financial accounting and income tax purposes.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

As of December 31, 2023, the principal components of deferred tax items were as follows (in thousands):

Net deferred income tax liabilities totalling $0.9 million at December 31, 2023, are classified as noncurrent liabilities in the accompanying combined balance sheet. At each balance sheet date, management assesses all available positive and negative evidence to determine whether a valuation allowance is needed against its deferred tax assets. The Company determined that the deferred tax assets are likely to be realized, and therefore do not require a valuation allowance. The amount of deferred tax assets considered realizable, however, could be adjusted if the weighting of the positive and negative evidence changes.

The Company follows the provisions of the authoritative guidance for accounting for uncertainty in income taxes which clarifies the accounting for uncertain income tax issues recognized in an entity’s financial statements. The guidance prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in an income tax return. The Company has not identified any tax issues that qualify under the authoritative guidance for uncertainty in income taxes.

The Company is not currently under examination by the Internal Revenue Service. State jurisdictions generally have statutes of limitations for tax returns ranging from three to five years. The state impact of federal income tax changes remains subject to examination by various states for a period of up to one year after formal notification to the states. Currently, the Company has various state income tax returns under examination.

Note 6. Commitments and Contingencies

Management continually evaluates contingencies based upon the best available information. In addition, allowances for losses are provided currently for disputed items that have continuing significance, such as certain third-party reimbursements and tax returns.

Management believes that allowances for losses have been provided to the extent necessary and that its assessment of contingencies is reasonable. Principal contingencies are described below:

Revenues

Certain third-party payments are subject to examination by agencies administering the various reimbursement programs. The Company is contesting the denial of certain payments by third parties to the Company’s customers.

Legal and regulatory proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s combined balance sheet and combined statement of operations.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

Obligations Under Insurance Programs

The Company is obligated for certain costs under various insurance programs maintained by KAH, including workers’ compensation, professional liability, property and general liability, and employee health and welfare.

The Company may be subject to workers’ compensation claims and lawsuits alleging negligence or other similar legal claims. KAH and Humana maintain various insurance programs to cover this risk with insurance policies subject to substantial deductibles and retention amounts. The Company recognizes its obligations associated with these programs in the period the claim is incurred. The cost of both reported claims and claims incurred but not reported, up to specified deductible limits, have generally been estimated based on historical data, industry statistics, the Company’s specific historical claims experience, current enrollment statistics and other information. The Company’s estimates of its obligations and the resulting reserves are reviewed and updated from time to time, but at least quarterly. The elements which impact this critical estimate include the number, type and severity of claims and the policy deductible limits; therefore, the estimate is sensitive and changes in the estimate could have a material impact on the Company’s combined financial statements.

The Company’s workers’ compensation and professional and general liability costs under these programs were $1.9 million in the year ended December 31, 2023. Workers’ compensation and professional liability claims, including any changes in estimate relating thereto, are recorded primarily in cost of services sold in the Company’s combined statement of operations.

KAH maintains insurance coverage on individual claims under these programs and are responsible for the cost of individual workers’ compensation claims and individual professional liability claims up to policy deductibles occurrence. KAH also maintain excess liability coverage relating to professional liability and casualty claims. Payments under KAH’s workers’ compensation program are guaranteed by letters of credit. The Company records its share of costs under these programs. The Company believes that its present insurance coverage and reserves are sufficient to cover currently estimated exposures, but there can be no assurance that the Company will not incur liabilities in excess of recorded reserves or in excess of its insurance limits.

The Company provides employee health and welfare benefits under a self-insured program maintained by KAH. Employee health and welfare benefit costs were $2.2 million for the year ended December 31, 2023. Changes in estimates of the Company’s employee health and welfare claims are recorded in cost of services sold for clinical associates and in selling, general and administrative costs for administrative associates in the Company’s statement of operations.

Note 7. Related Party Transactions

Support center allocations

The results of operations for the Company include allocations for certain support functions that were provided all or in part on a centralized basis by KAH, including cash management, information services support, accounts receivable processing, property and equipment record keeping, accounts payable processing, payroll and general bookkeeping. Additionally, KAH manages general business functions on behalf of the Company, including human resources, financial reporting and legal services. KAH refers to these expenses as support center allocations and they have been allocated based on a percentage of net revenues. The total allocated selling, general and administrative charges for the year ended December 31, 2023 was $18.0 million.

Debt and intercompany interest

The carve-out combined balance sheet does not include any third-party debt held by KAH and the combined statement of operations does not include any interest expense associated with the third-party debt held by KAH.

Employee benefits

The Company participates in defined contribution retirement plans sponsored by KAH covering employees who meet certain minimum eligibility requirements. Benefits are determined as a percentage of a participant’s contributions and generally are vested based upon length of service. Retirement plan expense for the Company was $0.4 million for the year ended December 31, 2023. Amounts equal to retirement plan expense are funded annually.

kah hospice company-Personal care

Notes to COMBINED financial statements (Continued)

Other intercompany balances

Transactions between the Company and KAH have been included in these combined financial statements. The transfers with KAH that are not expected to be settled, are reflected in net parent investment in the combined balance sheet and combined statement of net parent investment. The net parent investment was $305.0 million at December 31, 2023. Within the combined statement of cash flows, these transfers are treated as financing activities. Transactions between the Company and KAH or between the Company and Humana are considered related party transactions.

Note 8. Subsequent Events

These combined financial statements were derived from the financial statements of KAH, which issued its annual consolidated financial statements for the year ended December 31, 2023 on March 22, 2024. Accordingly, the Company has evaluated subsequent events for consideration as recognized subsequent events in these combined financial statements through the date of March 22, 2024. Additionally, the Company has evaluated subsequent events that occurred through February 14, 2025, the date these combined financial statements were available for issuance, for the purposes of unrecognized subsequent events. On December 2, 2024 Addus Homecare Corporation completed the acquisition of the Company for $350 million which was funded through a combination of cash on hand and its existing revolving credit facility.

Exhibit 99.2

KAH Hospice Company-Personal Care

(A carve-out business of KAH Hospice Company, Inc.)

Condensed Combined Financial Statements for the Nine Months Ended September 30, 2024 (Unaudited)

KAH Hospice company-PERSONAL CARE

Index

Page

kAh hospice company-Personal CARE

condensed COMBINED STATEMENT OF OPERATIONS (unaudited)

(In thousands)

See Accompanying Notes to Unaudited Combined Financial Statements.

kAh hospice company-Personal CARE

condensed COMBINED balance sheets (unaudited)

(In thousands)

See Accompanying Notes to Unaudited Combined Financial Statements.

kah hospice company-Personal CARE

condensed COMBINED statement of NET PARENT INVESTMENT (unaudited)

for the nine months ended September 30, 2024

(In thousands)

See Accompanying Notes to Unaudited Combined Financial Statements.

Kah hospice company-Personal care

condensed COMBINED Statement of CASH FLOWS (unaudited)

(In thousands)

See Accompanying Notes to Unaudited Combined Financial Statements.

kah hospice company-Personal care

Notes to condensed COMBINED financial statements

Note 1. Basis of Presentation

Reporting Entity

On August 11, 2022, Clayton, Dubilier & Rice (“CD&R”) purchased 60% of the Equity interests of KAH from Humana, Inc. Previously, Humana owned 100% of the equity interests of KAH.

On June 8, 2024, Curo Health Services, LLC (“Curo”), a subsidiary of KAH, entered into a Stock and Asset Purchase Agreement with Addus Healthcare, Inc. Under the terms of the agreement, Curo sold the Company as defined as all of the outstanding equity interests in wholly owned subsidiaries of IntegraCare of Abilene, LLC, NP Plus, LLC, Girling Health Care Services of Knoxville, Inc. and Girling Health Care, Inc. as well as, certain assets relating to the personal care business from its wholly owned subsidiaries Central Arizona Home Health Care, Inc., Community Home Care & Hospice, LLC, TNMO Healthcare, LLC and Odyssey HealthCare Operating A, LP. Together, the outstanding equity interests and assets of the Company were purchased for $350 million. The transaction is expected to close in late 2024.

Principles of combination

The accompanying unaudited condensed combined financial statements of the Company and its subsidiaries and the notes thereto presented in this report have been prepared in accordance with the rules applicable to interim financial statements, and do not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements. In the opinion of the Company, the accompanying unaudited condensed financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of September 30, 2024, and its results of operations and cash flows for the nine months ended September 30, 2024. The condensed balance sheet at December 31, 2023 was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. Results for the periods ended September 30, 2024 are not necessarily indicative of the results to be experienced for the year ending December 31, 2024. These financial statements are prepared on the same basis as and should be read in conjunction with the Company’s audited combined financial statements and related notes for the year ended December 31, 2023.

The accompanying condensed combined financial statements of the Company and its subsidiaries have been derived from the combined financial statements and accounting records of KAH as if the Company had operated on a stand-alone basis during the periods presented and were prepared utilizing the management approach, in accordance with generally accepted accounting principles in the United States of America (“GAAP”).

The income tax amounts in these combined financial statements have been calculated based on a separate return

The condensed combined financial statements include an allocation of expenses related to certain KAH corporate functions as discussed in Note 4. The condensed combined financial statements also include revenues and expenses directly attributable to the Company and assets and liabilities specifically attributable to the Company. KAH’s third-party debt and related interest expense have not been attributed to the Company, because the Company is not the primary legal obligor of the debt and the borrowings are not specifically identifiable to the Company. The entities combined in these financial statements were part of KAH’s Collateral and Guarantee Requirement agreement pursuant to which the Company agreed, jointly and severally, fully and unconditionally to guarantee all of KAH’s obligations under the credit agreement. Additionally, the Company is part of KAH’s security agreement, pursuant to which a first-priority security interest was granted in substantially all present and future real, personal and intangible assets, including the

kah hospice company-Personal care

Notes to condensed COMBINED financial statements (Continued)

pledge of 100 percent of all outstanding capital stock of the Company’s subsidiaries to secure full payment of the obligations for the ratable benefit of the lenders. Net parent investment represents the Company’s cumulative earnings as adjusted for cash distributions and cash contributions from its parent.

The Company eliminates all intercompany transactions within the Company from its financial results. Transactions between the Company and KAH have been included in these condensed combined financial statements. The transfers with KAH that are not expected to be settled are reflected in net parent investment on the condensed combined balance sheets and condensed combined statement of net parent investment. Within the condensed combined statement of cash flow, these transfers are treated as an operating, financing or noncash activity determined by the nature of the transactions. Transactions between the Company and KAH or between the Company and Humana are considered related party transactions. Refer to Note 4 for more information regarding related party transactions.

Recently issued accounting requirements

Summary of significant accounting policies

Use of estimates

The preparation of the financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Significant estimates and assumptions are used for, but not limited to: (1) revenue reserves for contractual adjustments and uncollectible amounts; (2) fair value of acquired assets and assumed liabilities in business combinations; (3) asset impairments, including goodwill; (4) corporate allocations. Future events and their effects cannot be predicted with certainty; accordingly, the Company’s accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in its evaluation, as considered necessary. Actual results could differ from those estimates.

Revenues

kah hospice company-Personal care

Notes to condensed COMBINED financial statements (Continued)

The Company determines the transaction price based on gross charges for services provided, reduced by estimates for explicit and implicit price concessions. The Company’s estimates of contractual adjustments and uncollectible amounts require the exercise of judgment. Explicit price concessions include contractual adjustments provided to various payers. They are recorded for the difference between the Company’s standard rates and the contracted rates to be realized from patients and third-party payers. Implicit price concessions include discounts provided to self-pay, uninsured patients or other payers, adjustments resulting from regulatory reviews, audits, billing reviews and other matters and are estimated by the Company based on historical collection experience and success rates in the claim appeals and adjudication process. The Company assesses the ability to collect for the services provided at the time of patient admission based on the verification of the patient’s insurance coverage under Medicaid, commercial insurance and other payers. Subsequent changes to the estimate of the transaction price are recorded as adjustments to net revenue in the period of change. Subsequent changes that are determined to be the result of an adverse change in the patient’s ability to pay (i.e. change in credit risk) are recorded as a provision for doubtful accounts within selling, general and administrative expenses.

A summary of revenue by payer type follows (in thousands):

Deferred Revenue

HCBS spending plans for the additional matching funds vary by state, but common initiatives in which the Company is participating include those aimed at strengthening the provider workforce (e.g. efforts to recruit and retain direct service providers). The Company is required to properly and fully document the use of such funds in reports to the state in which the funds originated. Funds may be subject to recoupment if not expended or if they are expended on non-approved uses. In total, the Company received state funding provided by ARPA in aggregate amount of $25.1 million. During the nine months ended September 30, 2024, the Company recorded revenue of $7.3 million and related costs of services sold of approximately $6.7 million. As of September 30, 2024 and December 31, 2023, the deferred portion of ARPA funding was $0.3 million and $7.6 million, respectively, and is reflected on the condensed combined balance sheet.

kah hospice company-Personal care

Notes to condensed COMBINED financial statements (Continued)

Accounts receivable

Allocated expense

All support center costs that were specifically identifiable to the Company have been allocated to the Company and are included in the accompanying condensed combined statement of operations. The results of operations for the Company include allocations for certain support functions that were previously provided on a centralized basis by KAH to all or part of the Company, including cash management, information technology services, accounts receivable oversight, property and equipment record keeping, accounts payable processing, payroll and general bookkeeping. Additionally, KAH manages general business functions on behalf of the Company, including human resources, financial reporting and legal services. KAH refers to these expenses as support center allocations and, where specific identification of charges attributable to the Company was not practicable, such costs have been allocated based on a percentage of net revenues.

In the opinion of management, the cost allocations have been determined on a reasonable basis and include all the costs of doing business. The amounts that would have been or will be incurred on a stand-alone basis could differ from the amounts allocated due to economies of scale, management judgment, or other factors. See Note 4 for additional information regarding related party transactions.

kah hospice company-Personal care

Notes to condensed COMBINED financial statements (Continued)

Note 2. Income Taxes

The Company’s effective tax rate for the nine months ended September 30, 2024 was 19.9%. For the nine months ended September 30, 2024, the effective tax rate was lower than the U.S. federal statutory rate of 21.0% primarily due to the Company’s qualifying for available Work Opportunity Tax Credits.

Federal and state tax expense included in the condensed consolidated statement of operations was $2.0 million for the nine months ended September 30, 2024.

Note 3. Commitments and Contingencies

Management believes that allowances for losses have been provided to the extent necessary and that its assessment of contingencies is reasonable. Principal contingencies are described below:

Revenues

Legal and regulatory proceedings

Obligations Under Insurance Programs

The Company’s workers’ compensation and professional and general liability costs under these programs were $1.4 million in the nine months ended September 30, 2024. Workers’ compensation and professional liability claims, including any changes in estimate relating thereto, are recorded primarily in cost of services sold in the Company’s condensed combined statement of operations.

kah hospice company-Personal care

Notes to condensed COMBINED financial statements (Continued)

currently estimated exposures, but there can be no assurance that the Company will not incur liabilities in excess of recorded reserves or in excess of its insurance limits.

The Company provides employee health and welfare benefits under a self-insured program maintained by KAH. Employee health and welfare benefit costs were $2.4 million for the nine months ended September 30, 2024. Changes in estimates of the Company’s employee health and welfare claims are recorded in cost of services sold for clinical associates and in selling, general and administrative costs for administrative associates in the Company’s statement of operations.

Note 4. Related Party Transactions

Support center allocations

Debt and intercompany interest

The carve-out condensed combined balance sheets do not include any third-party debt held by KAH and the condensed combined statement of operations do not include any interest expense associated with the third-party debt held by KAH.

Employee benefits

The Company participates in defined contribution retirement plans sponsored by KAH covering employees who meet certain minimum eligibility requirements. Benefits are determined as a percentage of a participant’s contributions and generally are vested based upon length of service. Retirement plan expense for the Company was $0.4 million for the nine months ended September 30, 2024. Amounts equal to retirement plan expense are funded annually.

Other intercompany balances

Transactions between the Company and KAH or between the Company and Humana have been included in these condensed combined financial statements. The transfers with KAH that are not expected to be settled, are reflected in net parent investment in the condensed combined balance sheets and condensed combined statement of net parent investment. The net parent investment at September 30, 2024 and December 31, 2023 was $306.5 million and $305.0 million, respectively. Within the condensed combined statement of cash flows, these transfers are treated as financing activities. Transactions between the Company and KAH or between the Company and Humana are considered related party transactions.

Note 5. Subsequent Events

The Company has evaluated subsequent events from September 30, 2024 through February 14, 2025, the date at which the condensed combined financial statements were available for issuance. On December 2, 2024 Addus Homecare Corporation completed the acquisition of the Company for $350 million which was funded through a combination of cash on hand and its existing revolving credit facility.

Exhibit 99.3

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Unaudited Pro Forma Condensed Combined Financial Information

The following unaudited pro forma combined financial information is presented to illustrate the effect of acquisition of the personal care business (the “Acquired Business”) of Curo Health Services, LLC, a Delaware limited liability company, which does business as Gentiva (“Gentiva”). The financial statements of KAH Hospice Company-Personal Care are in Exhibit 99.1 and we refer to KAH Hospice Company-Personal Care as Gentiva. The acquisition closed on December 2, 2024, and pursuant to the terms of the purchase agreement dated as of June 8, 2024, Addus HealthCare, Inc. (“Addus HealthCare” or the “Company”) acquired (A) all of the outstanding equity interests of (i) IntegraCare of Abilene, LLC, a Texas limited liability company, (ii) NP Plus, LLC, a Delaware limited liability company, (iii) Girling Health Care Services of Knoxville, Inc., a Tennessee corporation, and (iv) Girling Health Care, Inc., a Texas corporation and (B) certain assets and liabilities of (i) Central Arizona Home Health Care, Inc., an Arizona corporation, (ii) Community Home Care & Hospice, LLC, a Delaware limited liability company, (iii) TNMO Healthcare, LLC, a Delaware limited liability company, and (iv) Odyssey HealthCare Operating A, LP, a Delaware limited partnership, for an aggregate purchase price, in cash, of $350 million, subject to customary adjustments for working capital and other items. The purchase was funded through the Company’s existing revolving credit facility and a portion of the net proceeds of the Company’s public offering of common stock, which closed on June 28, 2024.

The following unaudited pro forma combined balance sheet as of September 30, 2024, and the unaudited pro forma combined statement of operations for the nine months ended September 30, 2024 and the year ended December 31, 2023 are based on the audited historical consolidated financial statements of Addus HealthCare as of and for the year ended December 31, 2023 and unaudited condensed interim financial statements of Addis HealthCare as of and for the nine months ended September 30, 2024 and the audited combined financial statements of KAH Hospice Company-Personal Care (a carve-out business of KAH Hospice Company, Inc.) as of and for the year ended December 31, 2023 and the unaudited condensed combined financial statements of KAH Hospice Company-Personal (a carve-out business of KAH Hospice Company, Inc.) as of and for the nine months ended September 30, 2024. The unaudited pro forma combined financial information gives effect to the Acquisition as if it occurred on (i) September 30, 2024 for the purposes of the unaudited pro forma combined balance sheet, and (ii) on January 1, 2023 for purposes of the unaudited pro forma combined statement of operations for the nine months ended September 30, 2024 and for the year ended December 31, 2023.

The unaudited pro forma combined financial data has been prepared using the acquisition method of accounting for business combinations under Generally Accepted Accounting Principles (“GAAP”). The adjustments necessary to fairly present the unaudited pro forma combined financial data have been made based on available information in the opinion of management are reasonable. Assumptions underlying the pro forma adjustments are described in the accompanying notes, which should be read in conjunction with this unaudited pro forma combined financial data. The pro forma adjustments relating to the acquisition of Gentiva are preliminary and revisions to the fair value of assets acquired and liabilities assumed may have a significant impact on the pro forma adjustments. A final valuation of assets acquired and liabilities assumed has not been completed and the completion of fair value determinations may result in changes in the values assigned to property and equipment and other assets (including intangibles) acquired and liabilities assumed.

The unaudited pro forma combined financial data is for illustrative purposes only and does not purport to represent what the Company’s financial position or results of operations actually would have been had the events noted above in fact occurred on the assumed dates or to project our financial position or results of operations for any future date or future period. The unaudited pro forma combined financial data should be read in conjunction with the consolidated financial statements and notes thereto of the Company and Gentiva.

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Pro forma Combined Balance Sheet

As of September 30, 2024

(Amounts in thousands)

(Unaudited)


	Addus		KAH Hospice Company-Personal Care Historical After Reclassifications (Note 3)		Transaction Accounting Adjustments				Pro Forma Combined
Assets
Current assets
Cash	$	222,852	$	90	$	(128,766	)	(b)	$	94,176
Accounts receivable, net of allowances		96,600		26,933		—				123,533
Prepaid expenses and other current assets		13,362		—		—				13,362
Total current assets		332,814		27,023		(128,766	)			231,071
Property and equipment, net of accumulated depreciation and amortization		23,716		1,585		(473	)	(a)		24,828
Other assets
Goodwill		663,614		287,699		29,155		(a)		980,468
Intangibles, net of accumulated amortization		86,606		13,596		19,404		(a)		119,606
Operating lease assets, net		44,535		5,273		190		(a)		49,998
Other long-term assets		1,616		123		—				1,739
Total other assets		796,371		306,691		48,749				1,151,811
Total assets	$	1,152,901	$	335,299	$	(80,490	)		$	1,407,710
Liabilities and stockholders' equity
Current liabilities
Accounts payable	$	27,726	$	896	$	—			$	28,622
Accrued payroll		57,982		5,935		—				63,917
Accrued expenses		34,257		11,394		—				45,651
Operating lease liabilities, current portion		11,155		1,817		—				12,972
Government stimulus advances		13,655		330		—				13,985
Accrued workers' compensation insurance		13,043		2,708		—				15,751
Total current liabilities		157,818		23,080		—				180,898
Long-term liabilities
Long-term debt, net of debt issuance costs		—		—		233,000		(b)		233,000
Long-term operating lease liabilities		38,608		3,388		—				41,996
Other long-term liabilities		8,841		2,342		4,765		(a)		15,948
Total long-term liabilities		47,449		5,730		237,765				290,944
Total liabilities	$	205,267	$	28,810	$	237,765			$	471,842
Stockholders' equity
Common stock	$	18	$	—	$	—			$	18
Additional paid-in capital		590,712		—		—				590,712
Retained earnings		356,904		306,489		(318,255	)	(c)		345,138
Total stockholders' equity		947,634		306,489		(318,255	)			935,868
Total liabilities and stockholders' equity	$	1,152,901	$	335,299	$	(80,490	)		$	1,407,710

See accompanying notes to unaudited pro forma financial information.

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Pro Forma Combined Statement of Operations

For the Nine Months Ended September 30, 2024

(Amounts and shares in thousands, except per share data)

(Unaudited)


	Addus			KAH Hospice Company-Personal Care			Transaction Accounting Adjustments				Pro Forma Combined
Net service revenues	$	857,455		$	210,823		$	—			$	1,068,278
Cost of service revenues		583,916			155,896			—				739,812
Gross profit		273,539			54,927			—				328,466
General and administrative expenses		187,444			43,506			72		(d)		231,022
Depreciation and amortization		10,316			1,433			1,870		(e)		13,619
Total operating expenses		197,760			44,939			1,942				244,641
Operating income		75,779			9,988			(1,942	)			83,825
Interest income		(2,805	)		(23	)		—				(2,828	)
Interest expense		5,445			34			11,239		(f)		16,718
Total interest expense, net		2,640			11			11,239				13,890
Income before income taxes		73,139			9,977			(13,181	)			69,935
Income tax expense		19,067			1,982			(3,436	)	(g)		17,613
Net income	$	54,072		$	7,995		$	(9,745	)		$	52,322
Net income per common share
Basic income per share	$	3.24									$	3.13
Diluted income per share	$	3.17									$	3.07
Weighted average number of common shares and potential common shares outstanding:
Basic		16,707										16,707
Diluted		17,065										17,065

See accompanying notes to unaudited pro forma financial information.

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Pro Forma Combined Statement of Operations

For the Year Ended December 31, 2023

(Amounts and shares in thousands, except per share data)

(Unaudited)


	Addus			KAH Hospice Company-Personal Care			Transaction Accounting Adjustments				Pro Forma Combined
Net service revenues	$	1,058,651		$	279,550		$	—			$	1,338,201
Cost of service revenues		718,775			201,925			—				920,700
Gross profit		339,876			77,625			—				417,501
General and administrative expenses		234,794			56,363			11,862		(h)		303,019
Depreciation and amortization		14,126			2,010			2,394		(e)		18,530
Total operating expenses		248,920			58,373			14,256				321,549
Operating income		90,956			19,252			(14,256	)			95,952
Interest income		(1,476	)		(12	)		—				(1,488	)
Interest expense		11,106			51			14,972		(f)		26,129
Total interest expense, net		9,630			39			14,972				24,641
Income before income taxes		81,326			19,213			(29,228	)			71,311
Income tax expense		18,810			3,713			(6,760	)	(g)		15,763
Net income	$	62,516		$	15,500		$	(22,468	)		$	55,548
Net income per common share
Basic income per share	$	3.91									$	3.47
Diluted income per share	$	3.83									$	3.41
Weighted average number of common shares and potential common shares outstanding:
Basic		15,996										15,996
Diluted		16,311										16,311

See accompanying notes to unaudited pro forma financial information.

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Notes to Pro Forma Combined Financial Statements

Note 1 – Description of the Transaction

On December 2, 2024, the Company completed the acquisition of Gentiva. The purchase price was approximately $350.0 million, and is subject to the completion of working capital and related adjustments. The purchase was funded with the combination of a $233.0 million draw on the Company’s revolving credit facility. With the Gentiva Acquisition, the Company expanded its services within its personal care services segment to Arizona, Arkansas, California, Missouri, North Carolina and Texas. The home health segment was expanded in Tennessee.

Note 2 – Basis of Presentation

The unaudited pro forma combined financial information is based on historical financial statements of the Company and Gentiva, as adjusted for the unaudited pro forma effects of the transaction. The unaudited pro forma combined financial information should be read in conjunction with:

•

the historical consolidated financial statements and accompanying notes of the Company included in its Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 27, 2024;

•

the unaudited historical condensed consolidated financial statements and accompanying notes of the Company included in its Quarterly Report on Form 10-Q for the nine months ended September 30, 2024 filed with the SEC on November 5, 2024;

•

the historical consolidated financial statements and accompanying notes of KAH Hospice Company-Personal Care for the calendar year ended December 31, 2023 included in this Amendment No. 1 to Current Report on Form 8-K; and

•

the historical unaudited condensed financial statements and accompanying notes of KAH Hospice Company-Personal Care as of September 30, 2024 and for the nine months ended September 30, 2024 also included in this Amendment No. 1 to Current Report on Form 8-K.

The unaudited pro forma combined balance sheet presents the financial position of the Corporation as if the transaction was consummated on September 30, 2024. The unaudited pro forma combined statements of operations for the nine months ended September 30, 2024 and for the year ended December 31, 2023 give effect as if the transaction was consummated on January 1, 2023.

The unaudited pro forma adjustments and related assumptions are described in the accompanying notes to the unaudited pro forma combined financial information. The unaudited pro forma combined financial information has been prepared based upon currently available information and assumptions that are deemed appropriate by the Corporation’s management. The unaudited pro forma combined financial information is for informational and illustrative purposes only and is not intended to be indicative of what actual results would have been had the transaction occurred on the dates assumed, nor does such data purport to represent the consolidated financial results of the Corporation for future periods. The actual financial position and results of operations may differ significantly from the unaudited pro forma amounts reflected herein due to a variety of factors.

The unaudited pro forma combined financial information of the Corporation was prepared in accordance with Article 11 of Regulation S-X.

Note 3 - Reclassification adjustments

The unaudited pro forma condensed combined balance sheet has been adjusted to reflect certain reclassifications of KAH Hospice Company-Personal Care’s consolidated financial statements to conform to Addus’ financial statement presentation.

Reclassification adjustments that have been made to the historical presentation of KAH Hospice Company-Personal Care to conform to the financial statement presentation of Addus are as follows (in thousands):


Addus Balance Sheet Presentation	KAH Hospice Company-Personal Care Balance Sheet Presentation	Before Reclassification		Reclassification			After Reclassification
Intangibles, net of accumulated amortization				$	13,596		$	13,596
	Certificates of need	$	4,400	$	(4,400	)
	Other intangible assets, net	$	9,196	$	(9,196	)
Accrued Payable				$	896		$	896
	Due to Payors	$	896	$	(896	)
Accrued payroll				$	5,935		$	5,935
	Payroll and related taxed	$	5,935	$	(5,935	)
Accrued expenses				$	11,394		$	11,394
	Other accrued expense	$	298	$	(298	)
	Income taxes payable	$	11,096	$	(11,096	)
Government stimulus advances				$	330		$	330
	American Rescue Plan Advance	$	330	$	(330	)
Accrued workers' compensation insurance				$	2,708		$	2,708
	Obligations under insurance programs	$	2,708	$	(2,708	)
Other long-term liabilities				$	2,342		$	2,342
	Obligations under insurance programs	$	1,714	$	(1,714	)
	Deferred income tax liability	$	628	$	(628	)
Retained earnings				$	306,489		$	306,489
	Net parent investment	$	306,489	$	(306,489	)

Note 4 – Purchase Consideration and Preliminary Purchase Price Allocation

The following preliminary schedule summarizes the consideration paid for Gentiva, the fair value of the assets acquired, and liabilities assumed. The final valuation could differ materially from the preliminary schedule summarized below. The excess of the aggregate fair value of the net tangible assets and identified intangible assets has been treated as goodwill in accordance with ASC 805. Management’s assessment of qualitative factors affecting goodwill includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Corporation operations, and the payor profile in the market.

Based upon management’s valuation, which is preliminary and subject to completion of working capital adjustments, the total purchase price has been allocated as follows:


Assets acquired and liabilities assumed (Amounts in Thousands)	Book Value			Adjustments			Fair Value
Cash		90			-			90		(i)
Accounts receivable, net		26,933			-			26,933		(i)
Property and equipment		1,585			(473	)		1,112		(ii)
Operating lease assets, net		5,273			190			5,463		(iii)
Intangible assets		9,196			19,404			28,600		(iv)
Goodwill		287,699			29,155			316,854		(v)
Other long-term assets		4,523			-			4,523		(i)
Accounts payable		(896	)		-			(896	)	(i)
Accrued expenses		(11,394	)		-			(11,394	)	(i)
Accrued payroll		(5,935	)		-			(5,935	)	(i)
Government stimulus advances		(330	)		-			(330	)	(i)
Accrued workers' compensation insurance		(2,708	)		-			(2,708	)	(i)
Operating lease liabilities, total		(5,205	)		-			(5,205	)	(i)
Other long-term liabilities		(2,342	)		(4,765	)		(7,107	)	(vi)
Total	$	306,489		$	43,511		$	350,000

(i)

A preliminary fair value equivalent to the current net book value has been assigned to the above respective acquired assets and assumed liabilities.

(ii)

Reflects the preliminary fair value adjustment relating to property and equipment.

(iii)

Reflects the preliminary net favorable lease assets adjustment.

(iv)

Reflects the preliminary fair value adjustment relating to identifiable intangible assets.


(Amounts in Thousands)	Estimated Fair Value
Intangible assets - Trade names	$	4,900
Intangible assets - Licenses		23,700
Total	$	28,600

(v)

The goodwill is measured as the excess of the purchase consideration over the fair value of identifiable assets acquired, less liabilities assumed.

(vi)

Reflects the preliminary estimate of deferred tax liabilities recognized on the estimated fair value adjustments to net assets acquired. This amount was calculated using an estimated blended statutory tax rate of 25.4%.

Note 5 – Transaction Accounting Adjustments

The pro forma adjustments are based on preliminary estimates that will likely differ from the final amounts the Company will calculate after completing a detailed valuation analysis, and any differences could have a material effect on the unaudited pro forma condensed consolidated financial statements or the Company’s financial statements for future periods.

The following is a summary of the unaudited pro forma adjustments reflected in the unaudited pro forma combined financial information. All adjustments are based on current valuations and assumptions, which are subject to change.

(a)

Reflects the preliminary purchase price allocation to the estimated fair value of identifiable assets acquired and liabilities assumed in the Acquisition, using the purchase method of accounting in Note 4.

(b)

Reflects the cash payment of $350.0 million for the acquisition of the Gentiva business and the payment of acquisition costs amounting to $11.8 million for the transaction, offset by draw on the Company’s revolving credit facility. The acquisition costs are non-recurring.


(Amounts in Thousands)	Total
Source:
Revolving Loan	$	233,000
Uses:
Gentiva cash consideration		(350,000	)
Acquisition costs		(11,766	)
Cash adjustment	$	(128,766	)

(c)

Reflects the elimination of the historical equity of Gentiva for an amount of $306.5 million and the impact to retained earnings from the recognition of the non-recurring acquisition related expenses of $11.8 million.

(d)

Reflects the adjustments to lease expense as a result of the net favorable lease assets.


						Pro Forma Lease Expense
(Amounts in Thousands)	Estimated Fair Value		Estimated Useful Life	Monthly Lease Expense		For the Nine Months Ended September 30, 2024		For the Year Ended December 31,2023
Favorable lease assets, net	$	190	Lease term	$	8	$	72	$	96

(e)

Represents the adjustments to depreciation and amortization expense as a result of recording the property and equipment and intangible assets at preliminary estimates of fair value as of the respective dates of the acquisitions, as follows:


						Pro Forma Depreciation and Amortization
(Amounts in Thousands)	Estimated Fair Value		Estimated Useful Life	Monthly Depreciation and Amortization		For the Nine Months Ended September 30, 2024			For the Year Ended December 31,2023
Furniture and equipment	$	523	5-7 years	$	9	$	81		$	108
Leasehold improvements		179	Lease term		10		90			120
Computer equipment		131	3-5 years		7		63			84
Computer software		279	3-10 years		13		117			156
		1,112
Tradename		4,900	3 years		136		1,224			1,632
Licenses		23,000	10 years		192		1,728			2,304
Licenses		700	indefinite life				-			-
		28,600					3,303			4,404
Less: historical depreciation and amortization expense							(1,433	)		(2,010	)
Pro forma adjustments						$	1,870		$	2,394

The acquisition method of accounting is dependent upon certain valuations that are provisional and subject to change. Accordingly, the pro forma adjustments are preliminary and made solely for the purpose of providing this unaudited pro forma combined financial information. A final determination of the fair value for certain assets and liabilities will be completed as soon as the information necessary to complete the analysis is obtained, but no later than one year from the acquisition date. Difference between these preliminary estimates and the final acquisition accounting may occur and these differences could be material.

For each 10% increase or decrease in the preliminary fair value of the intangible assets assuming a weighted-average remaining useful life of 8.77 years, annual amortization expense would increase or decrease by approximately $0.4 million

(f)

Represents adjustments of interest expense to the draw on the Company’s revolving credit facility with an estimated interest rate of 6.34%.


	Pro Forma Interest Expense
(Amounts in Thousands)	For the Nine Months Ended September 30, 2024			For the Year Ended December 31,2023
Revolving loan	$	233,000		$	233,000
Interest rate on closing of the transaction		6.34	%		6.34	%
Interest expense adjustments	$	11,239		$	14,972

The interest rates for pro forma purposes are based on the rates to be effective upon closing of the transaction. The revolving loan is subject to variable interest rates. Assuming 0.125% higher than the applicable rate would result in approximately $0.3 million change in the annual interest expense on the indebtedness under the Revolver.

(g)

Reflects tax adjustments using the Company’s combined federal and state statutory tax rates for the respective periods was 26.1% for the nine months ended September 30, 2024 and 23.1% for the year ended December 31, 2023.

(h)

Reflects the recognition of the non-recurring acquisition related expenses of $11.8 million, as described in note (b) above, and the adjustments to lease expense $0.1 million, as described in note (d) above.

Document and Entity Information	Dec. 02, 2024
Cover [Abstract]
Entity Registrant Name	Addus HomeCare Corp
Amendment Flag	true
Amendment Description	On December 2, 2024, Addus HomeCare Corporation (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) with the Securities and Exchange Commission to report that, on December 2, 2024, Addus HealthCare, Inc., an Illinois corporation (“Addus HealthCare”), a wholly-owned subsidiary of the Company, completed its acquisition of the personal care business (the “Acquired Business”) of Curo Health Services, LLC, a Delaware limited liability company, which does business as Gentiva (“Gentiva”). The financial statements of KAH Hospice Company-Personal Care are in Exhibit 99.1 and we refer to KAH Hospice Company-Personal Care as Gentiva. This Current Report on Form 8-K/A amends the Original Form 8-K to include Item 9.01 set forth below and provide the audited financial statements of the Acquired Business as of, and for the year ended December 31, 2023, the unaudited financial statements of the Acquired Business as of, and for the nine month period ended, September 30, 2024 and the unaudited pro forma combined financial statements as of, and for the nine month period ended, September 30, 2024, and for the year ended December 31, 2023. All other disclosures contained in the Original Form 8-K remain unchanged.
Entity Central Index Key	0001468328
Document Type	8-K/A
Document Period End Date	Dec. 02, 2024
Entity Incorporation, State or Country Code	DE
Entity File Number	001-34504
Entity Tax Identification Number	20-5340172
Entity Address, Address Line One	6303 Cowboys Way
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Frisco
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75034
City Area Code	(469)
Local Phone Number	535-8200
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	ADUS
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

Addus HomeCare (NASDAQ:ADUS)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Addus HomeCare Charts.

Addus HomeCare (NASDAQ:ADUS)
Historical Stock Chart
From Feb 2024 to Feb 2025

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ADUS Addus HomeCare Corp

Addus HomeCare Corp News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

ADUS Addus HomeCare Corp

Addus HomeCare Corp News

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free